Interactional Effects of Food Macronutrients with Gut Microbiome: Implications for Host Health and Risk.

J Agric Food Chem

Shaanxi Engineering Laboratory for Food Green Processing and Safety Control, and Shaanxi Key Laboratory for Hazard Factors Assessment in Processing and Storage of Agricultural Products, College of Food Engineering and Nutritional Science, Shaanxi Normal University, Xi'an 710119, China.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Macronutrients in the diet (e.g., carbohydrates, proteins, and lipids) that are rarely absorbed in the small intestine can typically traverse to the colon where they are metabolized by the gut microbiota to produce a spectrum of beneficial or detrimental metabolites. These gut-microbiota-dependent small-molecule metabolites are subsequently absorbed by the intestinal mucosa to participate in various physiological responses. Notably, succinate as a star dicarboxylic acid metabolite stemming from microbial fermentation of nondigestible carbohydrates regulates blood glucose homeostasis by promoting intestinal gluconeogenesis while inhibiting hepatic gluconeogenesis. Furthermore, protein- or tryptophan-derived indole metabolites have emerged as a promising target for modulating neuropathic diseases. Fascinatingly, the linkage between gut microbiota and lncRNA introduces a novel promising dimension for modulating lipid absorption, metabolism, and storage. Ongoing advancements in elucidating the interplay between macronutrients, gut microbiota, and host health may facilitate the development of gut microbiota-directed clinical precision nutrition strategies through intake of tailored macronutrients.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jafc.5c04034DOI Listing

Publication Analysis

Top Keywords

gut microbiota
12
macronutrients gut
8
host health
8
gut
5
interactional effects
4
effects food
4
macronutrients
4
food macronutrients
4
gut microbiome
4
microbiome implications
4

Similar Publications

Cancer is a multifaceted disease driven by a complex interplay of genetic predisposition, environmental factors and lifestyle habits. With the accelerating pace of cancer research, the gut microbiome has emerged as a critical modulator of human health and immunity. Disruption in the gut microbial populations and diversity, known as dysbiosis, has been linked with the development of chronic inflammation, oncogenesis, angiogenesis and metastasis.

View Article and Find Full Text PDF

Gut microbiota dysbiosis in people living with HIV who have cancer: novel insights and diagnostic potential.

Front Immunol

September 2025

Guangxi Key Laboratory of AIDS Prevention and Treatment & School of Public Health, Guangxi Medical University, Nanning, Guangxi, China.

Background: People living with HIV(PLWH) are a high-risk population for cancer. We conducted a pioneering study on the gut microbiota of PLWH with various types of cancer, revealing key microbiota.

Methods: We collected stool samples from 54 PLWH who have cancer (PLWH-C), including Kaposi's sarcoma (KS, n=7), lymphoma (L, n=22), lung cancer (LC, n=12), and colorectal cancer (CRC, n=13), 55 PLWH who do not have cancer (PLWH-NC), and 49 people living without HIV (Ctrl).

View Article and Find Full Text PDF

Nutritional status, immunonutrition, and gut microbiome: a coming of age for immunotherapy?

Front Immunol

September 2025

Clinical Nutrition and Dietetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

In the last decades, immunotherapy has revolutionized cancer treatment. Despite its success, a significant number of patients fail to respond, and the underlying causes of ineffectiveness remain poorly understood. Factors such as nutritional status and body composition are emerging as key predictors of immunotherapy outcomes.

View Article and Find Full Text PDF

Background: Recent research has increasingly underscored a significant correlation between gut microbiota and obstructive sleep apnea (OSA). Probiotics have emerged as promising adjunctive interventions for OSA. Metabolites and their related biochemical pathways have emerged as important contributors to the development of OSA.

View Article and Find Full Text PDF

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a rising health issue linked to poor diet and gut microbiota dysbiosis. The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, high in polyphenols and anti-inflammatory nutrients, may help protect against MASLD. This study examined how adherence to the MIND diet relates to MASLD severity, focusing on hepatic steatosis, fibrosis, insulin resistance, inflammation, and gut microbiota diversity.

View Article and Find Full Text PDF